Kezar Life Sciences, Inc. (KZR) Total Debt (2021 - 2025)
Kezar Life Sciences (KZR) posted Total Debt of $6.7 million for Q3 2025, down 16.01% sequentially from $7.9 million in Q2 2025, and down 35.17% YoY from $10.3 million in Q3 2024.
Kezar Life Sciences, Inc. (KZR) Total Debt (2021 - 2025) Analysis & Trends
Kezar Life Sciences has reported Total Debt for 5 years, with the latest figure at $6.7 million in Q3 2025.
- Quarterly Total Debt fell 35.17% year-over-year to $6.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.7 million (down 35.17% YoY) and the FY2024 annual result came in at $10.3 million, up 2.57% from the prior year.
- Total Debt declined to $6.7 million in Q3 2025 per KZR's latest filing, from $7.9 million in the prior quarter.
- Over five years, Total Debt peaked at $10.3 million in Q4 2024 and troughed at $6.7 million in Q3 2025.
- A 5-year average of $9.6 million and a median of $9.9 million in 2022 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2025: Total Debt advanced 2.57% in 2024, then sank 35.17% in 2025.
- Over 5 years, Total Debt stood at $9.6 million in 2021, then rose by 2.2% to $9.8 million in 2022, then rose by 2.39% to $10.1 million in 2023, then rose by 2.57% to $10.3 million in 2024, then plunged by 35.58% to $6.7 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $6.7 million, $7.9 million, and $9.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 7.92 Mn |
| Mar 31, 2025 | 9.09 Mn |
| Dec 31, 2024 | 10.33 Mn |
| Sep 30, 2024 | 10.26 Mn |
| Jun 30, 2024 | 10.20 Mn |
| Mar 31, 2024 | 10.13 Mn |
| Dec 31, 2023 | 10.07 Mn |
| Sep 30, 2023 | 10.01 Mn |
| Jun 30, 2023 | 9.95 Mn |
| Mar 31, 2023 | 9.89 Mn |
| Dec 31, 2022 | 9.83 Mn |
| Sep 30, 2022 | 9.78 Mn |
| Jun 30, 2022 | 9.73 Mn |
| Mar 31, 2022 | 9.68 Mn |
| Dec 31, 2021 | 9.62 Mn |